NEW ENTERPRISE ASSOCIATES 16, L.P. - BLACK DIAMOND THERAPEUTICS, INC. -- SCHEDUL

Company

Black Diamond Therapeutics, Inc.

Filed

February 13, 2020

Accession Number

0001072613-20-000093

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →